Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC challenges Belgium over laboratory practices:

This article was originally published in Clinica

Executive Summary

The European Commission has asked Belgium to change the conditions for reimbursement of medical analyses. The Commission has served Belgium with a Reasoned Opinion, asking it to modify certain provisions of Royal Decree 143 of December 30 1982, whereby non-Belgian laboratories are at a disadvantage compared to certain Belgian professionals. Only laboratories which meet the "restrictive conditions imposed by this Royal Decree", the Commission stated last week, may provide services eligible for reimbursement by the sickness insurance scheme, thus discouraging people covered by this from using laboratories which do not meet these conditions, in contravention of Article 43 of the EC Treaty on the freedom of establishment. Belgium has two months to respond, after which time the Commission may refer the case to the Court of Justice.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067509

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel